Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers
Clinical trial NCT01893528 · COMPLETED
Trial details
- NCT number
- NCT01893528
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-09-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.